{"database": "lobbying", "table": "lobbying_activities", "rows": [[2820234, "11b91b56-f183-409c-a151-ef5db0684aac", "Q2", "BLUESTONE STRATEGIES, LLC", 400658980, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2022, "second_quarter", "PHA", "Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2022-07-15T11:21:06-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2820234"], "units": {}, "query_ms": 18.267265055328608, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}